Roivant Sciences (ROIV) Tax Provisions (2020 - 2025)
Roivant Sciences (ROIV) posted Tax Provisions of $35.0 million for Q4 2025, up 400.01% on a QoQ basis from $7.0 million in Q3 2025, and up 236.8% year-over-year from $10.4 million in Q4 2024.
Roivant Sciences (ROIV) Tax Provisions (2020 - 2025) Analysis & Trends
Roivant Sciences' Tax Provisions history runs 6 years deep, the most recent figure standing at $35.0 million for Q4 2025.
- Quarterly Tax Provisions rose 236.8% year-over-year to $35.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.1 million (down 19.43% YoY) and the FY2026 annual result came in at $133.3 million, up 176.77% from the prior year.
- Tax Provisions was $35.0 million for Q4 2025 at Roivant Sciences, up from $7.0 million in the prior quarter.
- Across five years, Tax Provisions topped out at $35.0 million in Q4 2025 and bottomed at -$25.6 million in Q4 2024.
- A 5-year average of $6.3 million and a median of $4.0 million in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2022 — Tax Provisions surged 4200.0% — and 2024, when it sank 193.74%.
- Roivant Sciences' Tax Provisions stood at $532000.0 in 2021, then surged by 1588.53% to $9.0 million in 2022, then soared by 203.64% to $27.3 million in 2023, then sank by 193.74% to -$25.6 million in 2024, then surged by 236.8% to $35.0 million in 2025.
- Business Quant data shows ROIV's Tax Provisions at $35.0 million in Q4 2025, $7.0 million in Q3 2025, and $4.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34.98 Mn |
| Sep 30, 2025 | 7.00 Mn |
| Jun 30, 2025 | 4.65 Mn |
| Dec 31, 2024 | -25.57 Mn |
| Sep 30, 2024 | 12.46 Mn |
| Jun 30, 2024 | 11.96 Mn |
| Dec 31, 2023 | 27.28 Mn |
| Sep 30, 2023 | 3.24 Mn |
| Jun 30, 2023 | 1.75 Mn |
| Dec 31, 2022 | 8.98 Mn |
| Sep 30, 2022 | 2.17 Mn |
| Jun 30, 2022 | 4.00 Mn |
| Dec 31, 2021 | 532,000.00 |
| Sep 30, 2021 | 401,000.00 |
| Jun 30, 2021 | 93,000.00 |
| Dec 31, 2020 | -224,000.00 |
| Sep 30, 2020 | 711,000.00 |
| Jun 30, 2020 | 1.22 Mn |